| Early progression after bendamustine-rituximab is associated with high risk of transformation in advanced stage follicular lymphoma CL Freeman, R Kridel, AA Moccia, KJ Savage, DR Villa, DW Scott, ... Blood, The Journal of the American Society of Hematology 134 (9), 761-764, 2019 | 112 | 2019 |
| Diffuse large B‐cell lymphoma with testicular involvement: outcome and risk of CNS relapse in the rituximab era R Kridel, D Telio, D Villa, LH Sehn, AS Gerrie, T Shenkier, R Klasa, ... British journal of haematology 176 (2), 210-221, 2017 | 109 | 2017 |
| High-resolution architecture and partner genes of MYC rearrangements in lymphoma with DLBCL morphology LC Chong, S Ben-Neriah, GW Slack, C Freeman, D Ennishi, A Mottok, ... Blood advances 2 (20), 2755-2765, 2018 | 92 | 2018 |
| Survival outcomes of younger patients with mantle cell lymphoma treated in the rituximab era JN Gerson, E Handorf, D Villa, AS Gerrie, P Chapani, S Li, LJ Medeiros, ... Journal of Clinical Oncology 37 (6), 471-480, 2019 | 90 | 2019 |
| Observation as the initial management strategy in patients with mantle cell lymphoma P Abrisqueta, DW Scott, GW Slack, C Steidl, A Mottok, RD Gascoyne, ... Annals of Oncology 28 (10), 2489-2495, 2017 | 89 | 2017 |
| Long-term results of PET-guided radiation in patients with advanced-stage diffuse large B-cell lymphoma treated with R-CHOP CL Freeman, KJ Savage, DR Villa, DW Scott, L Srour, AS Gerrie, ... Blood, The Journal of the American Society of Hematology 137 (7), 929-938, 2021 | 74 | 2021 |
| Outcomes in splenic marginal zone lymphoma: analysis of 107 patients treated in British Columbia KH Xing, A Kahlon, BF Skinnider, JM Connors, RD Gascoyne, LH Sehn, ... British journal of haematology 169 (4), 520-527, 2015 | 73 | 2015 |
| Evaluation of the risk of relapse in classical Hodgkin lymphoma at event-free survival time points and survival comparison with the general population in British Columbia G Hapgood, Y Zheng, LH Sehn, D Villa, R Klasa, AS Gerrie, T Shenkier, ... Journal of Clinical Oncology 34 (21), 2493-2500, 2016 | 71 | 2016 |
| TMEM30A loss-of-function mutations drive lymphomagenesis and confer therapeutically exploitable vulnerability in B-cell lymphoma D Ennishi, S Healy, A Bashashati, S Saberi, C Hother, A Mottok, FC Chan, ... Nature medicine 26 (4), 577-588, 2020 | 68 | 2020 |
| Burkitt lymphoma international prognostic index AJ Olszewski, LH Jakobsen, GP Collins, K Cwynarski, V Bachanova, ... Journal of clinical oncology 39 (10), 1129-1138, 2021 | 67 | 2021 |
| D (T) PACE as salvage therapy for aggressive or refractory multiple myeloma AS Gerrie, JR Mikhael, L Cheng, H Jiang, V Kukreti, T Panzarella, ... British journal of haematology 161 (6), 802-810, 2013 | 66 | 2013 |
| Outcome of primary mediastinal large B-cell lymphoma using R-CHOP: impact of a PET-adapted approach AR Hayden, P Tonseth, DG Lee, D Villa, AS Gerrie, DW Scott, ... Blood, The Journal of the American Society of Hematology 136 (24), 2803-2811, 2020 | 65 | 2020 |
| Prognostic model to predict post-autologous stem-cell transplantation outcomes in classical Hodgkin lymphoma FC Chan, A Mottok, AS Gerrie, M Power, M Nijland, A Diepstra, ... Journal of Clinical Oncology 35 (32), 3722-3733, 2017 | 61 | 2017 |
| Fludarabine and rituximab for relapsed or refractory hairy cell leukemia AS Gerrie, LN Zypchen, JM Connors Blood, The Journal of the American Society of Hematology 119 (9), 1988-1991, 2012 | 61 | 2012 |
| Outcome of patients with non-Hodgkin lymphomas with concurrent MYC and BCL2 rearrangements treated with CODOX-M/IVAC with rituximab followed by hematopoietic stem cell … H Sun, KJ Savage, A Karsan, GW Slack, RD Gascoyne, CL Toze, ... Clinical Lymphoma Myeloma and Leukemia 15 (6), 341-348, 2015 | 59 | 2015 |
| Chemoresistance can be overcome with high-dose chemotherapy and autologous stem-cell transplantation for relapsed and refractory Hodgkin lymphoma AS Gerrie, MM Power, JD Shepherd, KJ Savage, LH Sehn, JM Connors Annals of oncology 25 (11), 2218-2223, 2014 | 57 | 2014 |
| Rituximab with high‐dose methotrexate in primary central nervous system lymphoma R Kansara, TN Shenkier, JM Connors, LH Sehn, KJ Savage, AS Gerrie, ... American journal of hematology 90 (12), 1149-1154, 2015 | 55 | 2015 |
| Genetic subgroups inform on pathobiology in adult and pediatric Burkitt lymphoma N Thomas, K Dreval, DS Gerhard, LK Hilton, JS Abramson, RF Ambinder, ... Blood 141 (8), 904-916, 2023 | 49 | 2023 |
| Molecular determinants of clinical outcomes in a real-world diffuse large B-cell lymphoma population W Alduaij, B Collinge, S Ben-Neriah, A Jiang, LK Hilton, M Boyle, ... Blood, The Journal of the American Society of Hematology 141 (20), 2493-2507, 2023 | 44 | 2023 |
| The impact of MYC and BCL2 structural variants in tumors of DLBCL morphology and mechanisms of false-negative MYC IHC B Collinge, S Ben-Neriah, L Chong, M Boyle, A Jiang, T Miyata-Takata, ... Blood, The Journal of the American Society of Hematology 137 (16), 2196-2208, 2021 | 44 | 2021 |
